PSIL

AdvisorShares$19.25-0.32 (-1.64%)
AUM $32.3MER 1.84%NAV $19.98Holdings 25

Price Chart

Key Statistics

Previous Close

$19.57

Day Range

$19.25$19.55

52-Week Range

$11.16$21.59

Avg Volume

76.3K

Dividend Yield

10.70%

Expense Ratio

1.84%

AUM

$32.3M

Shares Outstanding

1.0M

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare100.00%

Country Allocation

CountryWeight %
United States71.79%
United Kingdom9.52%
Ireland9.13%
Canada8.69%
Other0.47%
Australia0.39%

Fund Information

Category
Healthcare
Types
Active
Inception Date
Sep 15, 2021
Exchange
NYSE_ARCA
Description
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

Similar ETFs

SymbolNameAUM
IWMiShares Russell 2000 ETF$75.96B
XLVState Street Health Care Select Sector SPDR ETF$38.76B
VHTVanguard Health Care ETF$18.60B
VTWOVanguard Russell 2000 ETF$14.50B
IWOiShares Russell 2000 Growth ETF$13.72B

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund issued by AdvisorShares that launched on Sep 15, 2021. It currently manages $32.3M in assets under management. The fund charges an expense ratio of 1.84%. The fund holds 25 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 68.2% of the fund

RankSymbolNameWeight %SharesMarket Value
1ATAIATAIBECKLEY INC11.07%773,782$3.6M
2CMPSCOMPASS PATHWAYS PLC9.96%336,380$3.2M
3RLMDRELMADA THERAPEUTICS INC8.67%389,056$2.8M
4DFTXDefinium Therapeutics, Inc8.65%124,526$2.8M
5GHRSGH RESEARCH PLC5.57%89,037$1.8M
6NRXPNRX PHARMACEUTICALS INC5.45%600,485$1.8M
7DRUGBRIGHT MINDS BIOSCIENCES INC5.07%18,415$1.6M
8HELPCYBIN INC4.62%266,669$1.5M
9STIMNEURONETICS INC4.55%876,851$1.5M
10ANROALTO NEUROSCIENCE INC4.55%60,048$1.5M
11NBIXNEUROCRINE BIOSCIENCES INC4.13%10,469$1.3M
12ALKSALKERMES PLC3.87%37,626$1.3M
13SUPNSUPERNUS PHARMACEUTICALS INC3.66%23,817$1.2M
14ABBVABBVIE INC3.65%5,947$1.2M
15JNJJOHNSON & JOHNSON3.58%5,088$1.2M

Detailed Returns

PeriodReturnETF
1D
-1.64%
1W
-4.28%
1M
+20.77%
3M
+12.48%
6M
-3.43%
YTD
+11.92%
1Y
+70.27%
3Y
+11.92%
5Y
-80.71%

Moving Averages

20-Day MA

$18.55

Above 20-Day MA
50-Day MA

$17.55

Above 50-Day MA
200-Day MA

$17.74

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$21.59

Current Price

$19.25

52-Week Low

$11.16

$11.16$21.59

Current Yield

10.70%

Annual Dividend

$1.8793

Frequency

4x/year

Last Ex-Date

Dec 22, 2025

Dividend History

Ex-DateAmountPay Date
Dec 22, 2025$1.6839Dec 29, 2025
Sep 22, 2025$0.0201Sep 29, 2025
Jun 23, 2025$0.0119Jun 27, 2025
Mar 21, 2025$0.1634Mar 28, 2025
Dec 23, 2024$0.0548Dec 30, 2024
Sep 23, 2024$0.1087Sep 30, 2024
Sep 25, 2023$0.0034Sep 29, 2023
Sep 26, 2022$0.0542Sep 30, 2022

Dividend Payments Over Time

Category Comparison

MetricPSILHealthcare(212 ETFs)Active(633 ETFs)
Fund Info
Expense Ratio1.84%0.61%0.80%
AUM$32.3M$1.20B$325.7M
Dividend Yield10.70%3.25%6.78%
Avg Volume76.3K339.2K143.2K
Holdings2518183
Performance
1-Month Return+20.80%+7.61%+5.49%
6-Month Return-1.44%+4.67%-1.71%
YTD Return+13.98%+1.95%+1.76%
1-Year Return+67.53%+27.17%+10.71%

Compare with Another ETF

Search for an ETF to compare with PSIL:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.